Anticardiolipin antibodies during hormone replacement therapy in healthy postmenopausal women

Maturitas

Volumn 48, Issue 4, 2004, Pages 393-397

  Todorova, Maria ^a   Kamenov, Zdravko ^a   Baleva, Marta ^a   Christov, Vladimir ^a   Nicolov, Krassimir ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Anticardiolipin antibodies; HRT; Postmenopausal women

Indexed keywords

CARDIOLIPIN ANTIBODY; ESTRADIOL PLUS NORETHISTERONE ACETATE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AMENORRHEA; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; NORMAL HUMAN; POSTMENOPAUSE; THROMBOSIS;

ANTIBODIES, ANTICARDIOLIPIN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MIDDLE AGED; POSTMENOPAUSE;

EID: 3342982928     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2003.10.009     Document Type: Article

References (30)

1. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet. 353:1999;1348-1353
2. Levine J., Branch W., Rauch J. The antiphospholipid syndrome. N. Engl. J. Med. 346(10):2002;752-763
3. Metzer W.S., Canoso R.T., Newton J.E. Anticardiolipin antibodies in a sample of chronic schizophrenics receiving neuroleptic therapy. South Med. J. 87(2):1994;190-192
4. Schwartz M., Rochas M., Weller B., Sheinkman A., Tal I., Golan D., et al. High association of anticardiolipin antibodies with psychosis. J. Clin. Psychiatry. 59(1):1998;20-23
5. Asherson R., Zulman J., Hughes G. Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies. Ann. Rheum. Dis. 48:1989;232-235
6. Bick R.L., Baker W.F. Antiphospholipid and thrombosis syndrome. Semin. Thromb. Hemost. 20:1994;3-15
7. Ahmed S.A., Verthelyi D. Antibodies to cardiolipinin normal C57BL/6J mice: induction by estrogen, but not dihydrotestosterone. J. Autoimmun. 6(3):1993;265-279
8. Verthelyi D., Ahmed S. Characterization of estrogen induced autoantibodies to cardiolipin in non-autoimmune mice. J. Autoimmun. 10(2):1997;115-125
9. Petri M. Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy. Lupus. 10:2001;222-226
10. Mok C., Lau C., Wong R. Use of exogenous estrogens in systemic lupus erythematosus. Semin. Arthritis. Rheu. 30:2001;426-435
11. Daly E., Vessey M.P., Hawkins M.M., Carson J.L., Gough P., Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet. 348:1996;977-980
12. Jick H., Derby L.E., Meyers M., Vasilakis C., Newton K.M. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet. 348:1996;981-983
13. Van Baal W., Emeis J., van der Mooren M., Kessel H., Kenemans P., Stehouwer C. Impaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomised, placebo-controlled 12-week study. Thromb. Haemost. 83:2000;29-34
14. Kroon U.B., Silfverstolpe G., Tengborn L. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables. Thromb. Haemost. 71:1994;420-423
15. de Valk-de Roo G., Stehouwer C., Emeis J., Nicolaas-Merkus A., Netelenbos C. Unopposed estrogen increases total plasma factor VII, but not active factor VII. Thromb. Haemost. 84:2000;968-972
16. Winkler U., Altkemper R., Kwee B., Helmond F., Bennink H. Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study. Fertil. Steril. 74:2000;10-19
17. Lowe G.D., Upton M.N., Rumley A., McConnachie A., O'Reilly D.S., Watt G.C. Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-P.A., PAI and C-reactive protein - a cross-sectional population survey. Thromb. Haemost. 86:2001;550-556
18. Douketis J.D., Gordon M., Johnston M., Julian J.A., Adachi J.R., Ginsberg J.S. The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature. Thromb. Res. 99:2000;25-34
19. Van Baal W., Kenemans P., van der Mooren M., Kessel H., Emeis J., Stehouwer C. Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women. Thromb. Haemost. 81:1999;925-928
20. Walsh B.W., Paul S., Wild R.A., Dean R.A., Tracy R.P., Cox D.A., et al. The effect of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J. Clin. Endocrinol. Metab. 85:2000;214-218
21. Pierangeli S., Liu X., Barker J., Anderson G., Harris E. Induction of thrombosis in a mouse model by IgG. Thromb. Haemost. 74(5):1995;1361-1367
22. Wu R., Nityanand S., Berglund L., Lithell H., Holm G., Lefvert A. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arter. Thromb. Vasc. Biol. 17:1997;3159-3163
23. Levine S., Salowich-Palm L., Sawaya K., Perry M., Spencer H., Winkler H., et al. IgG anticardiolipin antibody titer>40 GPL and the risk of subsequent thrombo-occlusive events and death. Stroke. 28:1997;1660-1665
24. Hamsten A., Norberg R., Björkholm M., de Faire U., Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet. 1:1986;113-116
25. Ginsburg K.S., Liang M.H., Newcomer L., Goldhaber S., Schur P., Hennekens C., et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann. Intern. Med. 117:1992;997-1002
26. Szczepanski M., Cieslak E., Gardas A., Bauer A., Majkowski J. Prevalence of high IgM anticardiolipins in patients with ischemic stroke. Eur. J. Neurol. 5(3):1998;287-290
27. Morton K.E., Gavaghan T.P., Krilis S.A., Dagghard G., Baron D.W., Hickie J.B., et al. Coronary artery bypass graft failure: an autoimmune phenomenon? Lancet. 2:1986;1353-1357
28. Androniki B., Moss A., Francis C., Zareba W., Watelet L., Sanz I. Anticardiolipin antibodies and recurrent coronary events. A prospective study of 1150 patients. Circulation. 102:2000;1258-1263
29. Gharavi A.E., Harris E.N., Asherson R.A., Hughes G.R.V. Antiphospholipid antibodies: isotype distribution and phospholipid specificity. Ann. Rheumat. Dis. 46:1987;1-6
30. Luong T.H., Rand J., Wu X., Godbold J., Gascon-Lema M., Tuhrim S. Seasonal distribution of antiphospholipid antibodies. Stroke. 32:2001;1707-1711